key: cord-0990958-0jo7um7a authors: Law, Siukan; Leung, Albert Wingnang; Xu, Chuanshan title: Is the traditional Chinese herb “Artemisia annua” possible to fight against COVID-19? date: 2020-07-15 journal: Integr Med Res DOI: 10.1016/j.imr.2020.100474 sha: 5b6cb9f15792791efc563aef1d3fd4583436467a doc_id: 990958 cord_uid: 0jo7um7a nan This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Artemisinin is the most important bioactive component in Artemisia annua. The chemical structure of artemisinin is a sesquiterpene lactone containing an unusual endoperoxide bridge with chemical formulas C15H22O5 and a molecular weight of 282.332 g/mol. This unusual endoperoxide bridge is the key active site for its drug mechanism of action. However, artemisinin has certain limitations such as poor water insolubility and bioavailability, so various semi-synthetic derivatives developed including dihydroartemisinin, β-artemether and artesunate which exhibit To conclude the above information, the traditional Chinese herb "Artemisia annua" is possible to combat COVID-19. However, much more work needs to be done for supporting the evidence including its safety and efficacy to fight against COVID-19. All authors contributed to the concept, drafting of the article, and critical revision for important intellectual content. J o u r n a l P r e -p r o o f The history of qing hao in the Chinese materia medica Artemisia annua as a self-reliant treatment for malaria in developing countries World Health Organization. Update on artemisinin resistance Accessed 22 th Identification of natural compounds with antiviral activities against SARS-associated coronavirus The authors declare no conflict of interest. This research received no grant from any funding agency. This research did not require ethical approval as it does not involve any human or animal experiments. Not applicable.